Loading companies…
United States · Healthtech
Structured data and AI agents for clinical development and pharmaceutical trial operations.
Faro AI builds data infrastructure for clinical drug development and AI agents to automate work across clinical trials. Its platform is intended to help pharmaceutical teams organize trial information and streamline development processes, with Merck Global Health Innovation Fund among the co-leads of the Series B. The company raised $37.3 million to expand its clinical-development agent capabilities.
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $37.3M | S32 — LeadAnkona Capital — ParticipantGeneral Catalyst — ParticipantPolaris Partners — Participant |